Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "U.S.FDA.-Hari-S-Bhartia"

1 News Found

Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA
Biotech | October 01, 2021

Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA

The company plans to submit the IND application by the end of 2021